← Back to Search

Training Tool for HIV/AIDS Prevention (PhatLife-II Trial)

Led By David R Smith, PhD
Research Sponsored by Oregon Research Behavioral Intervention Strategies, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
English-speaking will be an inclusion criterion as the training and curriculum are only offered in English
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up post-training (6-weeks)
Awards & highlights

PhatLife-II Trial Summary

This trial is testing a new way to train people who work with juvenile offenders, in order to help them better address the offenders' co-morbid health problems.

Who is the study for?
This trial is for staff at certain sites who work with justice-involved youth. Participants must be able to speak English, as the training and curriculum are provided only in that language.Check my eligibility
What is being tested?
The study is testing a technology-based training tool called PHAT Life designed to help prevent HIV/AIDS among teens involved in the criminal justice system. It includes interactive multimedia, video examples, quizzes, games, and more.See study design
What are the potential side effects?
Since this trial involves an educational tool rather than a medical intervention, there are no direct physical side effects associated with participating in this study.

PhatLife-II Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I speak English.

PhatLife-II Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-training (6-weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-training (6-weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change over time in STI knowledge needed for HIV prevention
Secondary outcome measures
Implementation Outcomes
Satisfaction with Technology-Based Training
Sex Education Confidence Scale
+8 more

PhatLife-II Trial Design

2Treatment groups
Experimental Treatment
Group I: Technology Based Training Tool plus Live SupervisionExperimental Treatment1 Intervention
Participants randomized to this condition will receive (in addition to the training tool described above) access to live supervision delivered remotely via commercially available video conferencing software (Zoom). Facilitators-in-training will complete two mock roleplays of curriculum activities, which can be conducted live via Zoom with PHAT Life trainers (either Dr. Floyd or Dr. Snow-Hill) or can be recorded and submitted via the app. Trainers will review for fidelity and provide feedback. During the supervision sessions, participants will have the opportunity to clarify content, ask questions, roleplay group sessions to practice difficult parts of the group sessions, and review feedback on role plays.
Group II: Technology Based Training Tool OnlyExperimental Treatment1 Intervention
The technology-based training tool will train facilitators to deliver the behavioral health intervention PHAT Life, which is an innovative HIV/STI, substance use, and mental health intervention for juvenile offenders. The training tool reviews each of PHAT Life's 8 sessions. The curriculum targets broad psychosocial factors implicated in HIV/STI-risk behavior, including promoting positive attitudes toward HIV/STI prevention, self-efficacy to reduce risk, and less substance misuse and sexual risk taking. Content emphasizes the importance of emotion regulation skills to manage strong feelings, uses goal setting and training in positive thought processes to plan ahead, encourages recognition of personal responsibility in future outcomes, and helps youth identify strategies and behaviors to accomplish short- and long-term goals.

Find a Location

Who is running the clinical trial?

Oregon Research Behavioral Intervention Strategies, Inc.Lead Sponsor
20 Previous Clinical Trials
9,034 Total Patients Enrolled
University of Illinois at ChicagoOTHER
607 Previous Clinical Trials
1,559,226 Total Patients Enrolled
David R Smith, PhDPrincipal InvestigatorOregon Research Behavioral Intervention Strategies, Inc.
2 Previous Clinical Trials
450 Total Patients Enrolled

Media Library

Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life Clinical Trial Eligibility Overview. Trial Name: NCT05339412 — N/A
HIV/AIDS Research Study Groups: Technology Based Training Tool Only, Technology Based Training Tool plus Live Supervision
HIV/AIDS Clinical Trial 2023: Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life Highlights & Side Effects. Trial Name: NCT05339412 — N/A
Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life 2023 Treatment Timeline for Medical Study. Trial Name: NCT05339412 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment currently taking place for this experiment?

"The information on clinicaltrials.gov indicates that this specific trial is not presently seeking out new candidates, as it was last updated on October 28th 2022. However, there are 1029 other trials open for enrollment at the time of writing."

Answered by AI

How is this research endeavor expected to yield results?

"The primary assessment for this study, conducted over a six-week period post-training, will measure Fidelity. Secondary outcomes include Utilization measured by the length of time spent in each of four training areas (information, support, video and assessment), Implementation Outcomes scored on an Adoption scale with twelve items presented on a five point Likert Scale; an Implementation scale comprising five items using a ten-point rating system; Acceptability evaluated through six questions presented with four points to choose from; Appropriateness assessed via five queries rated according to another four point format; Maintenance gauged through six measures recorded on seven levels. Additionally"

Answered by AI
~87 spots leftby Apr 2025